Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
clinical trials
deals
fda
life sciences
national blog main
national top stories
new york blog main
new york top stories
novartis
3
×
alnylam pharmaceuticals
biotech
boston top stories
new york
sanofi
abbvie
achromatopsia
akouos
alirocumab
allergan
amag pharmaceuticals
amgen
amunix
anirvan ghosh
astrazeneca
beta-thalassemia
bill cassidy
biogen
bluebird bio
bluerock therapeutics
boulder/denver blog main
boulder/denver top stories
cancer
cancer immunotherapy
cerovene
covid-19
crispr
deerfield management
detroit blog main
detroit top stories
What
deal
3
×
medicines
years
acquire
acquisitions
age
agreed
announced
bigger
biggest
billion
bio
brings
cash
ceo
cholesterol
collabs
come
company
compound
covid
daniel
drug
emerging
fda
gave
gene
gilead
gilead’s
help
introduce
ipo
j
johnson
medco
meiragtx
month
morning
new
novartis
Language
unset
Current search:
novartis
×
deal
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
5 years ago
With $100M MeiraGTx Deal, J&J Signals Bigger Move Into Gene Therapy